These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 28865727)

  • 1. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
    Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
    Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Cardiac Mitochondrial Molecular and Functional Responses to Acute Anthracycline Treatment in Wistar Rats.
    Pereira GC; Pereira SP; Pereira FB; Lourenço N; Lumini JA; Pereira CV; Bjork JA; Magalhães J; Ascensão A; Wieckowski MR; Moreno AJ; Wallace KB; Oliveira PJ
    Toxicol Sci; 2019 May; 169(1):137-150. PubMed ID: 30698778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.
    Marques-Aleixo I; Santos-Alves E; Torrella JR; Oliveira PJ; Magalhães J; Ascensão A
    Cardiovasc Toxicol; 2018 Feb; 18(1):43-55. PubMed ID: 28536949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the Keap1/Nrf2-Antioxidant Response System After Chronic Doxorubicin Exposure In Vivo.
    Nordgren KKS; Wallace KB
    Cardiovasc Toxicol; 2020 Dec; 20(6):557-570. PubMed ID: 32500386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
    Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's Highlight: The Altered DNA Methylome of Chronic Doxorubicin Exposure in Sprague Dawley Rats.
    Nordgren KKS; Hampton M; Wallace KB
    Toxicol Sci; 2017 Oct; 159(2):470-479. PubMed ID: 28962528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes.
    Hanf A; Oelze M; Manea A; Li H; Münzel T; Daiber A
    Chem Biol Interact; 2019 Nov; 313():108834. PubMed ID: 31545955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
    Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
    Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
    Berthiaume JM; Wallace KB
    Cardiovasc Toxicol; 2007; 7(3):178-91. PubMed ID: 17901561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
    Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
    Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities.
    Li J; Wang PY; Long NA; Zhuang J; Springer DA; Zou J; Lin Y; Bleck CKE; Park JH; Kang JG; Hwang PM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19626-19634. PubMed ID: 31488712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
    Carvalho RA; Sousa RP; Cadete VJ; Lopaschuk GD; Palmeira CM; Bjork JA; Wallace KB
    Toxicology; 2010 Apr; 270(2-3):92-8. PubMed ID: 20132857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
    Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
    Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction.
    Berthiaume JM; Oliveira PJ; Fariss MW; Wallace KB
    Cardiovasc Toxicol; 2005; 5(3):257-67. PubMed ID: 16244371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
    Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise Training Prevents Doxorubicin-induced Mitochondrial Dysfunction of the Liver.
    Hinkley JM; Morton AB; Ichinoseki-Sekine N; Huertas AM; Smuder AJ
    Med Sci Sports Exerc; 2019 Jun; 51(6):1106-1115. PubMed ID: 30629044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.
    Chen X; Guo Z; Wang P; Xu M
    Heart Lung Circ; 2014 Aug; 23(8):772-7. PubMed ID: 24685074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.
    Ascensão A; Lumini-Oliveira J; Machado NG; Ferreira RM; Gonçalves IO; Moreira AC; Marques F; Sardão VA; Oliveira PJ; Magalhães J
    Clin Sci (Lond); 2011 Jan; 120(1):37-49. PubMed ID: 20666733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.